Characteristics of the 8 patients having developed NHL among the 500 patients with HL at CS IA/IIA
Group and histology of HL . | Sex . | Age at HL diagnosis, y . | Mos. from completion of therapy to NHL diagnosis . | Type of NHL . | NHL developed in an irradiated area . | Survival from NHL diagnosis, mo . | Status . |
|---|---|---|---|---|---|---|---|
| A | |||||||
| LPHL | M | 55 | 23 | DLBC NHL | Yes | 70 | Alive |
| B | |||||||
| cHL NS | M | 65 | 51 | DLBC NHL | No | 56 | Alive |
| cHL MC | M | 26 | 113 | Anaplastic LC NHL | Yes | 48 | Deceased |
| cHL MC | F | 62 | 13 | Peripheral T-cell NHL | No | 54 | Deceased |
| C | |||||||
| cHL NS | M | 33 | 183 | Small B-cell NHL | No | 6 | Alive |
| cHL NS | F | 32 | 171 | DLBC NHL | Yes | 36 | Deceased |
| cHL NS | M | 39 | 64 | DLBC NHL | No | 30 | Deceased |
| cHL MC | M | 45 | 75 | CNS DLBC NHL | No | 20 | Alive |
Group and histology of HL . | Sex . | Age at HL diagnosis, y . | Mos. from completion of therapy to NHL diagnosis . | Type of NHL . | NHL developed in an irradiated area . | Survival from NHL diagnosis, mo . | Status . |
|---|---|---|---|---|---|---|---|
| A | |||||||
| LPHL | M | 55 | 23 | DLBC NHL | Yes | 70 | Alive |
| B | |||||||
| cHL NS | M | 65 | 51 | DLBC NHL | No | 56 | Alive |
| cHL MC | M | 26 | 113 | Anaplastic LC NHL | Yes | 48 | Deceased |
| cHL MC | F | 62 | 13 | Peripheral T-cell NHL | No | 54 | Deceased |
| C | |||||||
| cHL NS | M | 33 | 183 | Small B-cell NHL | No | 6 | Alive |
| cHL NS | F | 32 | 171 | DLBC NHL | Yes | 36 | Deceased |
| cHL NS | M | 39 | 64 | DLBC NHL | No | 30 | Deceased |
| cHL MC | M | 45 | 75 | CNS DLBC NHL | No | 20 | Alive |
DLBC indicates diffuse large B-cell; NS, nodular sclerosis; MC, mixed cellularity; LC, large cell; CNS, central nervous system.